Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00788021 · ClinicalTrials.gov registry record
Protective Immunity Project 01
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 124
- Enrollment target
NCT00788021 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 124 participants.
The verdict
NCT00788021 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Patients who undergo kidney transplant must take medications to prevent organ rejection. There are standard immunosuppressant medications such as prednisone, tacrolimus (Prograf), mycophenolate mofetil(Cellcept) or sirolimus (Rapamune) that are given to patients to prevent rejection. It is well known that patients on immunosuppressant medications are at increased risk from viral infections, such as influenza. However, it is not well understood how immunosuppressive medications may uniquely affect the immune response to infection. This study will determine whether there are unique differences in the effects on the immune system by these different immunosuppressive medications, particularly differences between tacrolimus and sirolimus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2006-09 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00788021
The ClinicalTrials.gov registry entry for NCT00788021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00788021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00788021 about?
NCT00788021 is a clinical study titled "Protective Immunity Project 01". Patients who undergo kidney transplant must take medications to prevent organ rejection. There are standard immunosuppressant medications such as prednisone, tacrolimus (Prograf), mycophenolate mofetil(Cellcept) or sirolimus (Rapamune) that are given to patients to prevent rejection. It is well know...
What is the current status of trial NCT00788021?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2006-09. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00788021?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.